Treace Medical Concepts, Inc. (TMCI) Return on equity 2019–2025
Treace Medical Concepts, Inc. (TMCI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.6%FY2025 · since FY2019: -134.9% → -67.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.6% | -18.2 pp |
| FY2024 | -49.4% | -13.1 pp |
| FY2023 | -36.2% | +34.8 pp |
| FY2022 | -71.0% | -49.0 pp |
| FY2021 | -22.1% | +450.6 pp |
| FY2020 | -472.7% | -337.8 pp |
| FY2019 | -134.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice